Eve Johnstone

Q: What Schools Are Affiliated With Eve Johnstone

Eve Johnstone is affiliated with the following schools: Imperial College London, University of Oxford, University of Edinburgh, University of Glasgow

Eve Johnstone's AcademicInfluence.com Rankings

Eve Johnstone

Biology

#5613

World Rank

#8134

Historical Rank

Neuroscience

#660

World Rank

#689

Historical Rank

biology Degrees

Download Badge

Biology

Eve Johnstone's Degrees

Bachelors Neuroscience University of Oxford

Why Is Eve Johnstone Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Eve Cordelia Johnstone CBE FRCP FRCPE FRCPGla FRCPsych FMedSci FRSE is a Scottish physician, clinical researcher, psychiatrist and academic. Her main research area is in the field of schizophrenia and psychotic illness. She is Emeritus Professor of Psychiatry and Honorary Assistant Principal for Mental Health Research Development and Public Understanding of Medicine at the University of Edinburgh. She is best known for her 1976 groundbreaking study that showed brain abnormalities in schizophrenic patients compared to a control group.

(See a Problem?)

Eve Johnstone's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

CEREBRAL VENTRICULAR SIZE AND COGNITIVE IMPAIRMENT IN CHRONIC SCHIZOPHRENIA (1976) (1189)
Postmortem evidence of structural brain changes in schizophrenia. Differences in brain weight, temporal horn area, and parahippocampal gyrus compared with affective disorder. (1986) (690)
Schizophrenia as an anomaly of development of cerebral asymmetry. A postmortem study and a proposal concerning the genetic basis of the disease. (1989) (591)
Reduced frontotemporal functional connectivity in schizophrenia associated with auditory hallucinations (2002) (549)
Childhood antecedents of schizophrenia and affective illness: social adjustment at ages 7 and 11 (1994) (506)
MECHANISM OF THE ANTIPSYCHOTIC EFFECT IN THE TREATMENT OF ACUTE SCHIZOPHRENIA (1978) (458)
II. A Randomised Controlled Trial of Prophylactic Neuroleptic Treatment (1986) (450)
The Northwick Park Study of First Episodes of Schizophrenia (1986) (397)
Magnetic resonance imaging of brain in people at high risk of developing schizophrenia (1999) (366)
Predicting schizophrenia: findings from the Edinburgh High-Risk Study (2005) (350)
Structural disconnectivity in schizophrenia: a diffusion tensor magnetic resonance imaging study (2003) (336)
Spontaneous involuntary disorders of movement: their prevalence, severity, and distribution in chronic schizophrenics with and without treatment with neuroleptics. (1982) (327)
Grey matter changes over time in high risk subjects developing schizophrenia (2005) (311)
Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA (‘ecstasy’) users (1999) (299)
Schizophrenia and the brain: a prospective clinico-neuropathological study (1990) (288)
Brain structure, genetic liability, and psychotic symptoms in subjects at high risk of developing schizophrenia (2001) (288)
Progressive Gray Matter Loss in Patients with Bipolar Disorder (2007) (286)
Theory of mind and psychoses (1998) (273)
White matter abnormalities in bipolar disorder and schizophrenia detected using diffusion tensor magnetic resonance imaging. (2009) (267)
The Disabilities of Chronic Schizophrenia—their Nature and the Factors Contributing to their Development (1980) (258)
A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms (2006) (256)
Deficits in facial, body movement and vocal emotional processing in autism spectrum disorders (2010) (253)
Structural Gray Matter Differences between First-Episode Schizophrenics and Normal Controls Using Voxel-Based Morphometry (2002) (249)
White Matter Tractography in Bipolar Disorder and Schizophrenia (2008) (247)
Further Investigation of the Predictors of Outcome Following First Schizophrenic Episodes (1990) (243)
Complications of pregnancy and delivery in relation to psychosis in adult life: data from the British perinatal mortality survey sample. (1991) (222)
The effects of a neuregulin 1 variant on white matter density and integrity (2008) (218)
Lateral ventricular size in schizophrenia: relationship to the disease process and its clinical manifestations (1985) (214)
Temporal lobe structure as determined by nuclear magnetic resonance in schizophrenia and bipolar affective disorder. (1989) (209)
Neurotic illness and its response to anxiolytic and antidepressant treatment (1980) (207)
THE NORTHWICK PARK ELECTROCONVULSIVE THERAPY TRIAL (1980) (202)
Overactivation of Fear Systems to Neutral Faces in Schizophrenia (2008) (200)
Brain structure and function changes during the development of schizophrenia: the evidence from studies of subjects at increased genetic risk. (2007) (190)
Voxel-based morphometry of grey matter densities in subjects at high risk of schizophrenia (2003) (189)
Neuropsychological change in young people at high risk for schizophrenia: results from the first two neuropsychological assessments of the Edinburgh High Risk Study (2000) (183)
Peptides, the limbic lobe and schizophrenia (1983) (180)
Voxel-based morphometry of patients with schizophrenia or bipolar disorder and their unaffected relatives (2004) (174)
Dangerous Behaviour Preceding First Admissions for Schizophrenia (1992) (163)
Reduced cholecystokinin-like and somatostatin-like immunoreactivity in limbic lobe is associated with negative symptoms in schizophrenia. (1983) (162)
The spectrum of structural brain changes in schizophrenia: age of onset as a predictor of cognitive and clinical impairments and their cerebral correlates (1989) (155)
Genetic liability, illicit drug use, life stress and psychotic symptoms: preliminary findings from the Edinburgh study of people at high risk for schizophrenia (2001) (155)
Is there gliosis in schizophrenia? Investigation of the temporal lobe (1987) (153)
Adverse effects of anticholinergic medication on positive schizophrenic symptoms (1983) (151)
Affective Symptoms in Women Attending a Menopause Clinic (1994) (151)
fMRI correlates of state and trait effects in subjects at genetically enhanced risk of schizophrenia. (2003) (149)
IV. Expressed Emotion and Relapse (1986) (147)
Edinburgh high risk study — findings after four years: demographic, attainment and psychopathological issues (2000) (146)
IV. Performance on Psychological Tests. Demographic and Clinical Correlates of the Results of these Tests (1991) (144)
Correlates of insight and insight change in schizophrenia (1999) (143)
Functional disconnectivity in subjects at high genetic risk of schizophrenia. (2005) (143)
Neurodevelopmental indices and the development of psychotic symptoms in subjects at high risk of schizophrenia (2001) (143)
Neuropsychological assessment of young people at high genetic risk for developing schizophrenia compared with controls: preliminary findings of the Edinburgh High Risk Study (EHRS) (1999) (142)
Neuropsychological impairments in people with schizophrenia or bipolar disorder and their unaffected relatives (2005) (142)
Social cognition and face processing in schizophrenia (2004) (140)
White Matter Integrity in Individuals at High Genetic Risk of Bipolar Disorder (2011) (135)
A visual joke fMRI investigation into Theory of Mind and enhanced risk of schizophrenia (2006) (134)
Diffusion tensor imaging (DTI) and proton magnetic resonance spectroscopy (1H MRS) in schizophrenic subjects and normal controls (2001) (133)
Temporal lobe volume changes in people at high risk of schizophrenia with psychotic symptoms (2002) (130)
POSSIBLE VIRUS IN SCHIZOPHRENIA AND SOME NEUROLOGICAL DISORDERS (1979) (128)
Charting the landscape of priority problems in psychiatry, part 1: classification and diagnosis. (2016) (127)
Pathogenesis of schizophrenia: a psychopathological perspective (2005) (125)
Relationship of Catechol-O-Methyltransferase Variants to Brain Structure and Function in a Population at High Risk of Psychosis (2007) (123)
‘Pfropfschizophrenie’ revisited (1998) (122)
Genetic liability to schizophrenia or bipolar disorder and its relationship to brain structure (2006) (122)
People at risk of schizophrenia (1999) (121)
REDUCED NOCTURNAL MELATONIN SECRETION IN CHRONIC SCHIZOPHRENIA: RELATIONSHIP TO BODY WEIGHT (1982) (119)
Increased Prefrontal Gyrification in a Large High-Risk Cohort Characterizes Those Who Develop Schizophrenia and Reflects Abnormal Prefrontal Development (2007) (119)
Abnormal cortical folding in high-risk individuals: a predictor of the development of schizophrenia? (2004) (118)
Prefrontal function and activation in bipolar disorder and schizophrenia. (2008) (115)
Schizotypal components in people at high risk of developing schizophrenia: early findings from the Edinburgh High-Risk Study (2002) (114)
MECHANISM OF ACTION OF NEUROLEPTIC DRUGS (1978) (113)
Developmental arrest of cerebral asymmetries in early onset schizophrenia (1989) (113)
Institutionalization and the Defects of Schizophrenia (1981) (112)
Volumetric magnetic resonance imaging study of the brain in subjects with sex chromosome aneuploidies (1999) (111)
A diffusion tensor MRI study of white matter integrity in subjects at high genetic risk of schizophrenia (2008) (111)
Group psychological treatment for chest pain with normal coronary arteries. (1999) (109)
Concordance by Sex in Sibling Pairs with Schizophrenia is Paternally Inherited (1989) (108)
White Matter Density in Patients with Schizophrenia, Bipolar Disorder and Their Unaffected Relatives (2005) (108)
The 'continuum of psychosis': scientifically unproven and clinically impractical. (2010) (107)
Abnormal Involuntary Movements in Schizophrenia: Are They Related to the Disease Process or Its Treatment? Are They Associated with Changes in Dopamine Receptors? (1982) (106)
Life events in suicide and undetermined death in south-east Scotland: a case-control study using the method of psychological autopsy (1999) (105)
Validation of three dimensions of schizophrenic symptoms in a large unselected sample of patients (1996) (105)
Longitudinal Volume Reductions in People at High Genetic Risk of Schizophrenia as They Develop Psychosis (2011) (104)
Structural abnormalities of ventrolateral and orbitofrontal cortex in patients with familial bipolar disorder. (2009) (104)
Effects of ECT and Depression on Various Aspects of Memory (1983) (103)
Errorless learning and the cognitive rehabilitation of memory-impaired schizophrenic patients (1999) (102)
The Relative Stability of Positive and Negative Features in Chronic Schizophrenia (1987) (101)
Functional Imaging as a Predictor of Schizophrenia (2006) (98)
Symptomatology and social inference: A theory of mind study of schizophrenia and psychotic affective disorder (2005) (97)
Childhood behaviour, psychotic symptoms and psychosis onset in young people at high risk of schizophrenia: early findings from the Edinburgh High Risk Study (2002) (97)
Midbrain activation during Pavlovian conditioning and delusional symptoms in schizophrenia. (2010) (96)
Genetic variation in CNTNAP2 alters brain function during linguistic processing in healthy individuals (2011) (96)
Grey matter changes can improve the prediction of schizophrenia in subjects at high risk (2006) (96)
Gyrification in first-episode schizophrenia: a morphometric study (2004) (95)
DOPAMINE D2 RECEPTORS IN SCHIZOPHRENIA STUDIED IN VIVO (1986) (95)
Integration of Schematic Faces and Other Complex Objects in Schizophrenia (1983) (94)
Structural and Functional Abnormalities of the Amygdala in Schizophrenia (2003) (94)
White matter reduction in the parahippocampal gyrus of patients with schizophrenia. (1987) (92)
Neuropsychology, genetic liability, and psychotic symptoms in those at high risk of schizophrenia. (2003) (90)
Skin conductance responsivity during acute episodes of schizophrenia as a predictor of symptomatic improvement (1979) (87)
The Boundaries of the Cognitive Phenotype of Autism: Theory of Mind, Central Coherence and Ambiguous Figure Perception in Young People with Autistic Traits (2008) (85)
Prediction of Outcome Following a First Episode of Schizophrenia (1994) (85)
Schizophrenic Patients Discharged from Hospital—A Follow-up Study (1984) (84)
Dopaminergic mechanisms in schizophrenia: the antipsychotic effect and the disease process. (1978) (84)
Who Benefits from Electroconvulsive Therapy? (1992) (83)
Precursors and prodromata of schizophrenia: findings from the Edinburgh High Risk Study and their literature context (2006) (81)
Neuropsychological Performance Over Time in People at High Risk of Developing Schizophrenia and Controls (2006) (81)
Set shifting and reversal learning in patients with bipolar disorder or schizophrenia (2008) (80)
Acetylator status and response to phenelzine in depressed patients. (1973) (79)
Criminality and antisocial behaviour in unselected men with sex chromosome abnormalities (1999) (79)
Functional imaging of emotional memory in bipolar disorder and schizophrenia. (2009) (77)
A neuropsychological investigation into ‘Theory of Mind’ and enhanced risk of schizophrenia (2006) (76)
III. Short-term Outcome in Trial Entrants and Trial Eligible Patients (1986) (76)
Impact of a microRNA MIR137 Susceptibility Variant on Brain Function in People at High Genetic Risk of Schizophrenia or Bipolar Disorder (2012) (75)
Suicide and undetermined death in south east Scotland. A case–control study using the psychological autopsy method (1999) (72)
Prefrontal gyral folding and its cognitive correlates in bipolar disorder and schizophrenia (2009) (72)
Cortical thickness in first-episode schizophrenia patients and individuals at high familial risk: A cross-sectional comparison (2013) (71)
Evaluation of a Screening Instrument for Autism Spectrum Disorders in Prisoners (2012) (71)
Prevalence of Psychiatric Morbidity Among Remand Prisoners in Scotland (1995) (71)
Declarative memory in unaffected adult relatives of patients with schizophrenia: A systematic review and meta-analysis (2005) (71)
What does the Edinburgh high-risk study tell us about schizophrenia? (2002) (71)
Pre-frontal lobe gyrification index in schizophrenia, mental retardation and comorbid groups: An automated study (2007) (69)
The occurrence of organic disease of possible or probable aetiological significance in a population of 268 cases of first episode schizophrenia (1987) (69)
Low birthweight and preterm birth in young people with special educational needs: a magnetic resonance imaging analysis (2008) (68)
I. Background, Method, and General Description of the Sample (1991) (68)
The impact of substance use on brain structure in people at high risk of developing schizophrenia. (2011) (67)
Sustained attention in young people at high risk for schizophrenia (2002) (67)
Evidence for a Pseudo-autosomal Locus for Schizophrenia Using the Method of Affected Sibling Pairs (1991) (67)
DOPAMINE AND SCHIZOPHRENIA (1976) (66)
Structural MRI of the brain in presumed carriers of genes for schizophrenia, their affected and unaffected siblings (2002) (66)
A randomized, controlled trial of a brief interventional package for schizophrenic out‐patients (2001) (66)
Hippocampal function in schizophrenia and bipolar disorder (2009) (66)
The State Hospital survey: A description of psychiatric patients in conditions of special security in Scotland (1997) (66)
A Theory of Mind investigation into the appreciation of visual jokes in schizophrenia (2005) (64)
Neuroendocrine changes in acute schizophrenia as a function of clinical state and neuroleptic medication (1978) (64)
Antinuclear antibodies in psychiatric illness: their relationship to diagnosis and drug treatment. (1975) (63)
The Neural Basis of Familial Risk and Temperamental Variation in Individuals at High Risk of Bipolar Disorder (2011) (62)
Anterior pituitary hormone secretion in chronic schizophrenia – an approach to neurohumoral mechanisms (1977) (61)
Physical treatments. (1987) (61)
Service provision for people with schizophrenia (1997) (61)
Effects of ECT on Pituitary Hormone Release: Relationship to Seizure, Clinical Variables and Outcome (1983) (60)
The Northwick Park ‘Functional’ Psychosis Study: diagnosis and outcome (1992) (60)
Unsuspected organic disease in chronic schizophrenia demonstrated by computed tomography (1980) (60)
Schizophrenia: A Very Short Introduction (2003) (58)
Improved individualized prediction of schizophrenia in subjects at familial high risk, based on neuroanatomical data, schizotypal and neurocognitive features (2017) (58)
Comparative trial of L-tryptophan and E.C.T. in severe depressive illness. (1974) (58)
Hypofrontality revisited: a high resolution single photon emission computed tomography study in schizophrenia. (1995) (57)
Duration of untreated illness and outcome in schizophrenia: test of predictions in relation to relapse risk (2010) (57)
Increased Right Prefrontal Cortical Folding in Adolescents at Risk of Schizophrenia for Cognitive Reasons (2008) (57)
Platelet monamine oxidase in schizophrenia. An investigation in drug-free chronic hospitalized patients. (1976) (57)
A factor model of the functional psychoses and the relationship of factors to clinical variables and brain morphology (2001) (57)
Maternal recall bias, obstetric history and schizophrenia (2002) (56)
Charting the landscape of priority problems in psychiatry, part 2: pathogenesis and aetiology. (2016) (55)
Voxel-based morphometry of comorbid schizophrenia and learning disability: analyses in normalized and native spaces using parametric and nonparametric statistical methods (2004) (54)
Genetic Variation in the DAOA (G72) Gene Modulates Hippocampal Function in Subjects at High Risk of Schizophrenia (2008) (53)
Changes in Gyrification Over 4 Years in Bipolar Disorder and Their Association with the Brain-Derived Neurotrophic Factor Valine66 Methionine Variant (2009) (53)
Structural correlates of intellectual impairment and autistic features in adolescents (2006) (53)
The relationship of anterior thalamic radiation integrity to psychosis risk associated neuregulin-1 variants (2009) (52)
Correlations between fMRI activation and individual psychotic symptoms in un-medicated subjects at high genetic risk of schizophrenia (2007) (52)
CHARACTERISTICS OF PATIENTS WITH SCHIZOPHRENIA OR NEUROLOGICAL DISORDER AND VIRUS-LIKE AGENT IN CEREBROSPINAL FLUID (1979) (52)
The application of nonlinear Dynamic Causal Modelling for fMRI in subjects at high genetic risk of schizophrenia (2013) (51)
Automated computation of the Gyrification Index in prefrontal lobes: Methods and comparison with manual implementation (2006) (51)
Schizophrenia and influenza (1991) (51)
Empirical comparison of maximal voxel and non-isotropic adjusted cluster extent results in a voxel-based morphometry study of comorbid learning disability with schizophrenia (2005) (50)
The Outcome of Severe Acute Schizophrenic Illnesses After One Year (1979) (50)
Platelet Monoamine Oxidase Activity in Acute Schizophrenia: Relationship to Symptomatology and Neuroleptic Medication (1981) (49)
Service provision for people with schizophrenia (1997) (48)
Magnetic Resonance Imaging and Single Photon Emission Tomography in Treatment-Responsive and Treatment-Resistant Schizophrenia (1995) (47)
The coincidence of schizophrenia and Parkinsonism: some neurochemical implications (1976) (47)
Psychological morbidity and HIV in Kenya (1998) (46)
Lower effective connectivity between amygdala and parietal regions in response to fearful faces in schizophrenia (2012) (46)
Clinical Effects of Apomorphine in Schizophrenia (1984) (45)
Event-related fMRI of word classification and successful word recognition in subjects at genetically enhanced risk of schizophrenia (2006) (44)
Grey matter correlates of early psychotic symptoms in adolescents at enhanced risk of psychosis: A voxel-based study (2007) (43)
Emotional memory in schizophrenia (2007) (43)
Schizophrenia: From Neuroimaging to Neuroscience (2004) (42)
A common neural system mediating two different forms of social judgement (2009) (42)
Associative learning and the genetics of schizophrenia (2009) (42)
Hippocampal, amygdala and nucleus accumbens volume in first-episode schizophrenia patients and individuals at high familial risk: A cross-sectional comparison (2015) (41)
Genetic variants in the ErbB4 gene are associated with white matter integrity (2011) (41)
Orbitofrontal morphology in people at high risk of developing schizophrenia (2010) (41)
Specific cognitive deficits in a group at genetic high risk of schizophrenia (2009) (41)
Age Disorientation in Chronic Schizophrenia is Not Associated with Pre-morbid Intellectual Impairment or Past Physical Treatment (1988) (40)
Institutionalisation and the Outcome of Functional Psychoses (1985) (40)
Hormonal Effects of Apomorphine in Schizophrenia (1984) (40)
A magnetic resonance study of early schizophrenia. (1986) (39)
Presenilin-I, presenilin-II, and VLDL-R associations in early onset Alzheimer's disease (1997) (39)
Does tardive dyskinesia exist? (1983) (39)
Qualitative assessment of brain anomalies in adolescents with mental retardation. (2005) (38)
Uptake of 77Br‐spiperone in the striata of schizophrenic patients and controls (1986) (38)
Computational Neuropsychiatry – Schizophrenia as a Cognitive Brain Network Disorder (2014) (37)
Controlled Trials of Electroconvulsive Therapy (1986) (37)
Diagnostic stability in subjects with multiple admissions for psychotic illness (2001) (36)
Neurotransmitter Enzymes and Receptors in Post-mortem Brain in Schizophrenia: Evidence that an Increase in D2 Dopamine Receptors is Associated with the Type I Syndrome (1981) (36)
Comparative trial of L-tryptophan and amitriptyline in depressive illness (1977) (36)
A Follow-up Study of Severe Puerperal Psychiatric Illness (1981) (36)
Impact of cannabis use on thalamic volume in people at familial high risk of schizophrenia (2011) (35)
Phenomenology of Organic and Functional Psychoses and the Overlap Between Them (1988) (35)
Neuroimaging and molecular genetics of schizophrenia: pathophysiological advances and therapeutic potential (2008) (35)
Dangerous behaviour preceding first admissions for schizophrenia. (1993) (35)
Dopamine receptor changes in schizophrenia in relation to the disease process and movement disorder. (1983) (35)
Disabilities and circumstances of schizophrenic patients--a follow-up study. Cause of death. (1991) (35)
Expressed Emotion and Relapse in First Episodes of Schizophrenia (1987) (35)
The relationship between acetylator status and inhibition of monoamine oxidase, excretion of free drug and antidepressant response in depressed patients on phenelzine (1976) (34)
In Reply … A Locus Closer to the Telomere? (1990) (34)
Progressive temporal lobe grey matter loss in adolescents with schizotypal traits and mild intellectual impairment (2009) (34)
Disabilities and circumstances of schizophrenic patients--a follow-up study. Ethnic aspects. A Comparison of three matched groups. (1991) (34)
Self‐rated schizotypal cognitions, psychotic symptoms and the onset of schizophrenia in young people at high risk of schizophrenia (2002) (34)
Grey matter networks in people at increased familial risk for schizophrenia (2015) (33)
Combination tricyclic antidepressant and lithium maintenance medication in unipolar and bipolar depressed patients. (1990) (33)
Clinical correlates of postmortem brain changes in schizophrenia: decreased brain weight and length correlate with indices of early impairment. (1994) (33)
II. Social Outcome (1991) (33)
NeuroGrid: using grid technology to advance neuroscience (2005) (33)
Methodological issues in volumetric magnetic resonance imaging of the brain in the Edinburgh High Risk Project (1999) (33)
Temporal grey matter reductions in bipolar disorder are associated with the BDNF Val66Met polymorphism (2007) (32)
Time course of the antipsychotic effect in schizophrenia and some changes in postmortem brain and their relation to neuroleptic medication. (1980) (31)
Brain–behaviour relationships in people at high genetic risk of schizophrenia (2006) (31)
Effects of the BDNF Val66Met polymorphism on neural responses to facial emotion (2011) (31)
Distinguishing characteristics of subjects with good and poor early outcome in the Edinburgh High-Risk Study (2002) (31)
Dissociation of Brain Activation in Autism and Schizotypal Personality Disorder During Social Judgments (2017) (31)
Cortical Surface Area Differentiates Familial High Risk Individuals Who Go on to Develop Schizophrenia (2015) (31)
VI. Comparison of the 1975—85 Cohort with the 1970—75 Cohort (1991) (30)
Anterior Pituitary Hormone Secretion in Chronic Schizophrenics: Responses to Administration of Hypothalamic Releasing Hormones (1983) (30)
Reversal of proliferation deficits caused by chromosome 16p13.11 microduplication through targeting NFκB signaling: an integrated study of patient-derived neuronal precursor cells, cerebral organoids and in vivo brain imaging (2018) (30)
Determinants of the Extremes of Outcome in Schizophrenia (1995) (30)
Facial emotion recognition in Scottish prisoners. (2012) (29)
Facial and other non-verbal communicative behaviour in chronic schizophrenia (1996) (29)
Expressed Emotion and Relapse in Schizophrenia (1986) (29)
Functional magnetic resonance imaging of BDNF val66met polymorphism in unmedicated subjects at high genetic risk of schizophrenia performing a verbal memory task (2010) (28)
Neuroendocrine markers of CNS drug effects. (1980) (28)
The effects of DISC1 risk variants on brain activation in controls, patients with bipolar disorder and patients with schizophrenia (2011) (28)
fMRI changes over time and reproducibility in unmedicated subjects at high genetic risk of schizophrenia (2008) (27)
Gonadotrophin secretion abnormalities in chronic schizophrenia (1982) (27)
The two-syndrome concept and neuroendocrinology of schizophrenia. (1986) (27)
Abnormal cerebral asymmetry and schizophrenia in a subject with Klinefelter’s syndrome (XXY) (2003) (27)
Schizotypal cognitions as a predictor of psychopathology in adolescents with mild intellectual impairment (2007) (26)
Voxel-based morphometry of grey matter reductions in subjects at high risk of schizophrenia and the impact of specific templates (2002) (25)
How high is the relapse rate in schizophrenia? (1994) (25)
The Assessment of Negative and Positive Features in Schizophrenia (1989) (24)
Hypothyroidism as a Correlate of Lateral Ventricular Enlargement in Manic-Depressive and Neurotic Illness (1986) (24)
Skin conductance habituation during acute episodes of schizophrenia: qualitative differences from anxious and depressed patients (1982) (24)
Chemical and structural changes in the brain in patients with movement disorder. (1985) (24)
Does a four-week delay in the introduction of medication alter the course of functional psychosis? (1999) (23)
Social Cognition, the Male Brain and the Autism Spectrum (2012) (23)
The Edinburgh High Risk Study: current status and future prospects. (2003) (23)
Dermatoglyphics and schizophrenia: findings from the Edinburgh high risk study (2005) (22)
Hypofrontality in subjects at high genetic risk of schizophrenia with depressive symptoms. (2008) (22)
Polygenic risk for schizophrenia, transition and cortical gyrification: a high-risk study (2017) (22)
Neural Correlates of Enhanced Genetic Risk for Schizophrenia (2005) (21)
Schizophrenia in people with mild learning disability (1998) (21)
Autistic Traits and Cognitive Performance in Young People with Mild Intellectual Impairment (2008) (20)
DOPAMINE AND SCHIZOPHRENIA (1976) (20)
Obstetric complications and mild to moderate intellectual disability (2009) (20)
SCHIZOPHRENIA AND CEREBRAL ATROPHY (1980) (19)
VIRUS-LIKE AGENT IN CSF IN SCHIZOPHRENIA AND SOME NEUROLOGICAL DISORDERS (1982) (19)
Schizophrenia: problems in clinical practice (1993) (19)
II. Ascertainment of a population of people with early‐onset dementia in Lothian, Scotland (1999) (19)
Effects of the BDNF val66met polymorphism on prefrontal brain function in a population at high genetic risk of schizophrenia (2010) (18)
Selective Decreases in MAO-B Activity in Post-Mortem Brains from Schizophrenic Patients with Type II Syndrome (1987) (18)
Predictors of admission to a high-security hospital of people with intellectual disability with and without schizophrenia. (2001) (18)
CEREBRAL ATROPHY AND COGNITIVE IMPAIRMENT IN CHRONIC SCHIZOPHRENIA (1977) (18)
Anterior cingulate morphology in people at genetic high-risk of schizophrenia (2012) (17)
Genetic variation in the G72 (DAOA) gene affects temporal lobe and amygdala structure in subjects affected by bipolar disorder. (2009) (17)
Arousal related to excretion of noradrenaline metabolites and clinical aspects of unmedicated chronic schizophrenic patients. (1979) (17)
Disabilities and circumstances of schizophrenic patients--a follow-up study. Police contact. (1991) (17)
V. Cause of Death (1991) (17)
Social outcome. (1991) (17)
Effects of a mis‐sense DISC1 variant on brain activation in two cohorts at high risk of bipolar disorder or schizophrenia (2012) (17)
A GRIK4 variant conferring protection against bipolar disorder modulates hippocampal function (2009) (16)
A MRI study of ocular hypertelorism in individuals at high risk of developing schizophrenia (2001) (16)
Use of second-person pronouns and schizophrenia. (2012) (16)
Tensor-based morphometry of cannabis use on brain structure in individuals at elevated genetic risk of schizophrenia (2012) (15)
Brain structure change and psychopathology in subjects at high risk of schizophrenia (2000) (15)
Amygdala volume in a population with special educational needs at high risk of schizophrenia (2009) (15)
Systematic Review of the Clinical Presentation of Schizophrenia in Intellectual Disability (2011) (15)
Effect of Variation in Diacylglycerol Kinase Eta (DGKH) Gene on Brain Function in a Cohort at Familial Risk of Bipolar Disorder (2012) (14)
Negative symptoms and longitudinal grey matter tissue loss in adolescents at risk of psychosis: Preliminary findings from a 6-year follow-up study (2016) (14)
Measurement of lateral preferences and schizophrenia: results of the Edinburgh High-Risk Study and methodological issues (2004) (14)
Childhood adversity and cortical thickness and surface area in a population at familial high risk of schizophrenia (2015) (13)
The Viral Hypothesis of Schizophrenia: Some Experimental Approaches1 (1983) (13)
Anterior pituitary hormone secretion in chronic schizophrenics. (1983) (13)
Poor and mad: a study of patients admitted to the Fife and Kinross District Asylum between 1874 and 1899 (1996) (13)
The nature of ‘transient’ and ‘partial’ psychoses: findings from the Northwick Park ‘Functional’ Psychosis Study (1996) (13)
Longitudinal Gray Matter Change in Young People Who Are at Enhanced Risk of Schizophrenia Due to Intellectual Impairment (2013) (13)
Phenelzine in urine: assay and relation to acetylator status. (1976) (13)
The effects of chronic treatment with amitriptyline and diazepam on electrodermal activity in neurotic outpatients (1984) (13)
A comparison of some retrograde and anterograde effects of electroconvulsive shock in patients with severe depression. (1987) (13)
Small Intestine Permeability in Schizophrenia (1989) (12)
A survey of female patients in high security psychiatric care in Scotland. (2001) (12)
Laterality of visuo-spatial attention in acute and chronic schizophrenia, major depression and in healthy controls (1995) (12)
Determination of 3-methoxy-4-hydroxyphenylglycol conjugates in urine. Application to the study of central noradrenaline metabolism in unmedicated chronic schizophrenic patients (1976) (12)
PLATELET MONAMINE OXIDASE IN SCHIZOPHRENIA (1977) (12)
Early-onset dementia in Lothian, Scotland: an analysis of clinical features and patterns of decline. (1999) (12)
Offending among first episode schizophrenics (1994) (12)
III. Clinical Findings. Abnormalities of the Mental State and Movement Disorder and their Correlates (1991) (11)
Stereospecificity and clinical potency of neuroleptics (1977) (11)
Schizophrenia: Concepts and Clinical Management (1999) (10)
15 – Schizophrenia and related disorders (2010) (10)
The Disabilities of Chronic Schizophrenia (1980) (10)
The urinary excretion of phenelzine. (1978) (10)
Links between Autism Spectrum Disorder Diagnostic Status and Family Quality of Life (2016) (10)
VII. Police Contact (1991) (10)
What Is Crucial for the Long-Term Outcome of Schizophrenia? (1990) (9)
Attitudes of patients and family members towards implantable psychiatric medication (2008) (9)
Substance use, psychiatric symptoms and the onset of schizophrenic illness (2006) (9)
Differences between patients with schizophrenia within and without a high security psychiatric hospital (2000) (9)
The Northwick Park 'Functional' Psychosis Study. Phase 2: maintenance treatment (1991) (9)
VIII. Ethnic Aspects. A Comparison of Three Matched Groups (1991) (8)
I. Measuring the decline of a population of people with early‐onset dementia in Lothian, Scotland (1999) (8)
Benzodiazepines and Effectiveness of ECT (1982) (8)
Should the treatment of schizophrenia include old antipsychotic drugs? (2000) (8)
Schizophrenia is not due to maternal influenza in the second (or other) trimester of pregnancy (1992) (7)
Crow's 'Lateralization Hypothesis' for Schizophrenia-Reply (1991) (7)
Segmentation of the anterior thalamic radiation using neighbourhood tractography (2009) (7)
The relationships between clinical response, psychophysiological variables and plasma levels of amitriptyline and diazepam in neurotic outpatients (2004) (7)
Brief Report: The Association of Autistic Traits and Behavioural Patterns in Adolescents Receiving Special Educational Assistance (2015) (7)
Platelet monoamine oxidase activity in patients with chronic schizophrenic illnesses untreated by neuroleptic drugs [proceedings]. (1975) (7)
Disabilities and circumstances of schizophrenic patients--a follow-up study. Comparison of the 1975-85 cohort with the 1970-75 cohort. (1991) (7)
A study of enhanced management in patients with treatment-resistant schizophrenia (1997) (6)
Categorical and Dimensional Approaches to Examining the Joint Effect of Autism and Schizotypal Personality Disorder on Sustained Attention (2020) (6)
Evidence for executive dysfunction in young people at high genetic risk for schizophrenia? Results of the Hayling sentence completion test (1998) (6)
Blood levels of flupenthixol in patients with acute and chronic schizophrenia. (1979) (6)
The development of antipsychotic drugs (2018) (6)
3-Methoxy-4-hydroxyphenylglycol excretion in acutely schizophrenic patients during a controlled clinical trial of the isomers of flupenthixol (1979) (6)
Determinants of adult functional outcome in adolescents receiving special educational assistance. (2013) (6)
Childhood adversity and hippocampal and amygdala volumes in a population at familial high risk of schizophrenia (2016) (6)
The clinical effects of the isomers of flupenthixol--the consequences of dopamine receptor blockade in acute schizophrenia [proceedings]. (1977) (6)
Serum prolactin as an index of dopamine receptor blockade in acute schizophrenia [proceedings]. (1977) (6)
Pregnancy and birth complications as causes of psychiatric illness in adult life: A study utilizing the perinatal mortality survey (1958) (1990) (5)
Stereochemical specificity in the antipsychotic effects of flupenthixol in man [proceedings]. (1977) (5)
VIRUS-LIKE PARTICLES IN CSF IN SCHIZOPHRENIA (1979) (5)
EVIDENCE FOR A PSEUDOAUTOSOMAL LOCUS FOR SCHIZOPHRENIA (1989) (5)
The effect of an educational intervention on insight and suicidal ideation in schizophrenia (1998) (5)
Brain noradrenaline metabolism and psychophysiological variables in chronic schizophrenia (1976) (5)
Genetic liability, brain structure and symptoms of schizophrenia (2004) (5)
Depression in Functional Psychosis (1989) (4)
Onset, course and outcome of schizophrenia (1994) (4)
Predicting first episode psychosis in those at high risk for genetic or cognitive reasons (2012) (4)
Searching for the Causes of Schizophrenia (1994) (4)
Treatment and management of schizophrenia (2012) (4)
Acetylation of phenelzine (1979) (4)
Treatment and security needs of special hospital patients. By Tony Maden, Christine Curle, Clive Meux, Stephen Burrow and John Gunn. Whurr Publishers Limited, 19b Compton Terrace, London N1 2UN. March 1995, 132 pp. ISBN 1-897635-02-8 (1997) (4)
Small intestine permeability in schizophrenia. (1989) (4)
The relationship between response to phenelzine and acetylator status in depressed patients. (1973) (4)
Modulation of hippocampal activation by genetic variation in the GRIK4 gene (2009) (4)
Childhood antecedents of schizophrenia: Authors’ reply. (1995) (4)
Parcellating the temporal lobes from magnetic resonance images using generic software in subjects at high risk of developing schizophrenia (2006) (4)
L-dopa helps positive but not negative features of neuroleptic-insensitive chronic schizophrenia (1994) (4)
2103 – THE MECHANISM OF THE ANTIPSYCHOTIC EFFECT IN ACUTE SCHIZOPHRENIA (1978) (4)
Voxel based morphometry of grey matter reductions over time in subjects at high risk of schizophrenia (2003) (4)
Drs Johnstone, Macmillian and Crow Reply (1986) (3)
A new and familial variant of schizophrenia? (1996) (3)
Neurological changes in a population of patients with chronic schizophrenia and their relationship to physical treatment (1981) (3)
The Role of Dopamine in the Antipsychotic Effect and the Pathogenesis of Schizophrenia (1977) (3)
Towards an automated method for white matter integrity comparison between populations (2005) (3)
Treatment resistance in schizophrenia (1996) (3)
Associations of affective disorder in patients with inflammatory bowel disease (2011) (3)
Relationship between acetylator status and response to phenelzine. (1975) (3)
Clues to the Nature and Location of the Psychosis Gene: Is Schizophrenia Due to an Anomaly of the Cerebral Dominance Gene Located in the Pseudoautosomal Region of the Sex Chromosomes? (1989) (3)
Psychiatric disturbance and post-vagotomy diarrhoea. (1974) (3)
The use of videotaped assessment in relation to a study of enhanced management in treatment-resistant schizophrenia (1997) (3)
Neuropsychological assessment of a group of individuals at high genetic risk for schizophrenia and controls (1998) (3)
Dementia Praecox and Schizophrenia: Was Bleuler Wrong? (1980) (3)
Schizophrenia: Nature of the Disease Process and its Biological Correlates (2011) (3)
Childhood antecedents of schizophrenia and affective disorder — A prospective study (1992) (3)
A concept of schizophrenia (1993) (3)
Predictors of psychotic symptoms among young people with special educational needs (2019) (2)
The Phenomenological, Pharmacological and Psychophysiological Characteristics of Neurotic Outpatients to whom no Diagnosis has been Applied (1979) (2)
? a New and Familial Variant of Schizophrenia (1996) (2)
An Investigation of Platelet Monoamine Oxidase Activity in Schizophrenia and Schizoaffective Psychosis (2008) (2)
PHENELZINE AND ACETYLATOR STATUS (1974) (2)
Developmental abnormalities and symptoms in subjects at high risk of schizophrenia (2000) (2)
Early performance in subjects at high risk of developing schizophrenia (2000) (2)
Complications of pregnancy and delivery in relation to psychosis in adult life: A study using the perinatal mortality survey (1991) (2)
Relationship of COMT variants to brain structure, function and risk of psychosis (2006) (2)
Neural mechanisms controlling the secretion of corticotrophin releasing factor. (1981) (2)
A Trial of Real versus Simulated Electroconvulsive Therapy in 70 Depressed Patients (1981) (2)
SCHIZOPHRENIA AND INFLUENZA. REPLY (1991) (2)
Neuropsychological assessment in the Edinburgh high risk for schizophrenia study (2000) (2)
Growth hormone response to apomorphine. (1987) (2)
IX. Concluding Remarks (1988) (2)
1 – An introduction to psychiatry (2010) (2)
Defining characteristic of schizophrenia. (1991) (2)
Acute schizophrenia. (1985) (1)
23MODELING A GENETIC RISK FOR SCHIZOPHRENIA: PHENOTYPIC DIFFERENCES IN HUMAN NEURAL PRECURSORS AND CEREBRAL ORGANOIDS FROM PATIENTS WITH CHR16P13.11 MICRODUPLICATIONS (2019) (1)
Predictive symptomatology, course and outcome in first-episode schizophrenia (1998) (1)
Pfropf-schizophrenie revisited (1996) (1)
Voxel-based morphometry of co-morbid schizophrenia and learning disability: Analyses using parametric and nonparametric statistical methods (2004) (1)
MCQs for the companion to psychiatric studies (2000) (1)
Reductions of grey matter volume in subjects at high risk of schizophrenia (2001) (1)
Distinguishing characteristics of subjects Distinguishing characteristics of subjects with good and poor early outcome in the with good and poor early outcome in the (2002) (1)
Functional imaging in subjects at high risk of schizophrenia (2003) (1)
Voxel based morphometry of grey matter reductions in schizophrenia and the impact of generic versus specific normalisation templates (2001) (1)
269 Why poor performance on the Rivermead Behavioural Memory Test in schizophrenia is indicative of a specific disease process (1997) (1)
Social, medical and psychiatric aspects of schizophrenia in people with pre-morbid cognitive impairment (1998) (1)
Human Psychopharmacology: Measures and Methods (Vol. 1). Edited by I. Hindmarsh and P. H. Stonier. Chichester: John Wiley. 1987. 239 pp. £24.50. (1988) (1)
The incidence of antinuclear antibodies in relation to drug therapy in psychiatric patients [proceedings]. (1975) (1)
Structural imaging in subjects at high risk for schizophrenia (1998) (1)
A phenotypically male patient with a sex chromosome aneuploidy (Klinefelter's syndrome), abnormal cerebral asymmetry and schizophrenia (2000) (1)
Serotonin transporters in ecstasy users - Reply (2000) (1)
Dopamine and schizophrenia. (1976) (1)
Computed tomography after leucotomy (1980) (1)
Biologic Response Styles: Clinical Implications. Edited by Howard Klar and Larry J. Siever. Washington: American Psychiatrie Press. 1985. Pp. 95. $12.00. (1987) (1)
Can Schizophrenia be Localised in the Brain? Edited by Nancy Andreasen. Cambridge: Cambridge University Press. 1986. Pp 87. $15.00. (1987) (1)
A Controlled Clinical Trial of 5-Hydroxytryptophan (5HTP) in a Single Case of Lesch-Nyhan Syndrome Using Behavioural Ratings (1976) (1)
Patterns of grey matter loss discriminate between schizophrenia and bipolar disorder (2004) (1)
Poster #46 GREY MATTER DENSITY AND CORTICAL THICKNESS VARY WITH DIFFERENT ORBITOFRONTAL SULCOGYRAL PATTERNS (2012) (0)
Developing psychopathology in subjects at high risk of schizophrenia (2000) (0)
early outcome in the Edinburgh High-Risk Study Distinguishing characteristics of subjects with good and poor (2011) (0)
2. The concept of schizophrenia (2003) (0)
Biological psychiatry Concluding summary. (1996) (0)
Cognitive trait and state markers in subjects at genetic high risk (2007) (0)
Depression: An Integrative Approach (1988) (0)
450 MRI-determined brain volumes and schizotypal characteristics in subjects with sex chromosome anomalies and matched controls (1997) (0)
S32.03 - Evidence of shared white matter disruption in bipolar disorder and sschizophrenia (2008) (0)
8. The importance of schizophrenia (2003) (0)
Brain disease and psychopathology difficulties in diagnosis and patient management. (1999) (0)
Emotional factors in gastro-intestinal illness: Arthur Lindner: Excerpta Medica, Amsterdam. 1974. 000 pp., $18.50 (1975) (0)
CLINICAL AND IMAGING PREDICTION OF SCHIZOPHRENIA IN PEOPLE AT HIGH FAMILIAL RISK (2014) (0)
Psychiatry over there (1987) (0)
Title: Is there a symptomatic distinction between the affective psychoses and schizophrenia? A machine learning approach (2018) (0)
Clinical and cognitive markers of the development of schizophrenia (2002) (0)
Functional MRI of the Hayling test in high-risk subjects: Preliminary results (2002) (0)
Editorial Board (2009) (0)
Cerebral asymmetry and treatment response in schizophrenia (1998) (0)
Authors' reply (1991) (0)
MATERNAL RECALL OF OBSTETRIC HISTORY , AND SCHIZOPHRENIA obstetric complications ( (0)
Brain Imaging, Psychopathology and Neuropathology (1995) (0)
Neuroanatomy and psychopathology of co-morbid learning disability and schizophrenia (2002) (0)
Modelling a Genetic Risk for Schizophrenia in Human Induced Pluripotent Stem Cells (Ipscs): Phenotypic Differences in Patients with Mutations in Nde1 (2017) (0)
The relevance of pre-morbid cognitive deficit to the concept of “neurodevelopmental schizophrenia” (1995) (0)
What is the functional consequence of disturbed gyrification of the human brain? (2007) (0)
3. Intellectual functioning in schizophrenia (2003) (0)
The association between neuropsychology and psychotic symptoms in the Edinburgh high risk for schizophrenia study (2000) (0)
The Anatomy of the Functional Psychoses (1996) (0)
HOW DOES E.C.T. WORK? (1978) (0)
Drug Use in Psychiatry. By L. Evans, M. J. Eadie, L. Hollister and J. H. Tyrer. Bristol: Wright PSG. 1983. Pp 175. £22.50. (1984) (0)
Dr Crow and Colleagues Reply (1985) (0)
307 Detailed neuropsychological testing in treatment resistant and treatment responsive schizophrenia (1997) (0)
Determinants of Adult Outcome in Adolescents with Educational Difficulties (2017) (0)
5. Biological factors (2003) (0)
7. Understanding the symptoms of schizophrenia (2003) (0)
Probabilistic Independent Component Analysis of fMRI Data (2006) (0)
6. Environmental factors (2003) (0)
HOW DOES E.C.T. WORK? (1978) (0)
early impairment . weight and length correlate with indices of changes in schizophrenia : decreased brain Clinical correlates of postmortem brain (0)
Description of a Sample at High Risk for Schizophrenia and Controls (1996) (0)
The Edinburgh high risk (2007) (0)
Virus-Like Agents from Patients with Mental Diseases and Some Chronic Neurological Conditions (1979) (0)
Authors' reply (1993) (0)
437. Modeling Schizophrenia in Human Induced Pluripotent Stem Cells (hiPSCs): Phenotypic Differences in Patients with Mutations in NDE1 (2017) (0)
Functional disconnectivity in subjects at genetically enhanced risk of schizophrenia (2004) (0)
Can we identify an early target population in high risk studies? (2002) (0)
The Psychopharmacology and Treatment of Schizophrenia Edited by P. B. Bradley and S. R. Hirsch Oxford: Oxford University Press. 1986. Pp 457. $37.50. (1987) (0)
Structural disconnectivity in schizophrenia: Structural disconnectivity in schizophrenia: a diffusion tensor magnetic resonance imaging a diffusion tensor magnetic resonance imaging (2003) (0)
relationship to symptomatology and neuroleptic medication. Platelet monoamine oxidase activity in acute schizophrenia (2013) (0)
PHENELZINEINURINE: ASSAYAND RELATIONTOACETYLATORSTATUS (2000) (0)
Mild Head Injury. Edited by Harvey S. Levin, Howard M. Eisenberg and Arthur L. Benton. New York: Oxford University Press. 1989. 288 pp. £32. (1990) (0)
Brief Report: The Association of Autistic Traits and Behavioural Patterns in Adolescents Receiving Special Educational Assistance (2015) (0)
Editorial Preface (1991) (0)
Studyschizophrenia: findings from the Edinburgh High-Risk (2011) (0)
Differential Therapeutics in Psychiatry: The Art and Science of Treatment Selection. By Allen Frances, John Clarkin and Samuel Perry. New York: Brunner/Mazel. 1984. Pp 395. $30.00. (1985) (0)
Providing services for patients with schizophrenia: In-patient care—-the clinical and economic perspective (1995) (0)
Qualitative analysis of MR images from high risk, first episode schizophrenics and normal control subjects (2000) (0)
Outcome of Schizophrenic Illnesses (1979) (0)
Psychological Morbidity, Social Circumstances, Sexual Behaviour and Hiv in Kenyan Community Sample (1996) (0)
Functional MRI of the hayling sentence completion test in subjects at high risk of schizophrenia: preliminary results (2001) (0)
Background Neuropsychological abnormalities in schizophrenia arewell (2005) (0)
ECT — Does it work? (1978) (0)
Schizophrenia Research. Advances in Neuropsychiatry and Psychopharmacology Volume 1. Edited by C. A. Tamminga and C. S. Schulz. New York: Raven Press. 1991. 391 pp. $150.00. (1992) (0)
RECENT ADVANCES IN THE BIOLOGY OF SCHIZOPHRENIA (1974) (0)
Depression in IBD: Preliminary Results of the ISA (IBD, Steroids and Affective Disorder) Study (2011) (0)
The HAS—the quango's defence (1986) (0)
The Biochemistry of Schizophrenia and Addiction. Edited by Gwynneth Hemmings. Lancaster: MTP Press. 1980. Pp 344. £17.95. - The Biochemistry of Psychiatric Disturbances. Edited by G. Curzon Chichester: John Wiley. 1980. Pp 144. £13.00. (1981) (0)
Clinical psychopharmacology: Second edition. edited by Jerrold G. Bernstein. John Wright Barton, 1984. Price not known (1985) (0)
Drs Crow and Johnstone reply (1984) (0)
Functional MRI of a verbal memory encoding and retrieval task in subjects at high risk of schizophrenia: Preliminary results (2001) (0)
Researching the Autism Spectrum: Brain imaging and the neuroanatomical correlates of autism (2011) (0)
T113. CATEGORICAL AND DIMENSIONAL APPROACHES EXAMINING THE JOINT EFFECT OF AUTISM AND SCHIZOTYPAL PERSONALITY DISORDER ON SUSTAINED ATTENTION (2020) (0)
Principles and Practice of Biological Psychiatry, Vols I and II. Edited by T. G. Dinan. CNS Publishers, London, 1990. Vol. I, viii + 346 pp.; vol. II, viii + 332 pp. ISBN: Vol. I, 1–869–868–72–2; Vol. II, 1–869–868–73–0 (1992) (0)
1. The experience of schizophrenia (2003) (0)
4. Schizophrenia and drugs (2003) (0)
Book ReviewAGGROAggression and Dangerousness, D.P. Farrington, J. Gunn (Eds.), John Wiley & Sons, Chichester (1985), p. 271, index, £28.50, ISBN: 0 471 90556 9 (1985) (0)
Treating psychiatric symptom with TMS (2002) (0)
Structural and functional MRI in the Edinburgh high risk study (2002) (0)
SIRS 5th Biennial Schizophrenia International Research Meeting-Florence, April 2016: Possibilities and Pitfalls-Reflections on 42 Years in Academic Psychiatry and Lessons for a Suggested Repeat Performance. (2017) (0)
S.14.05 The Edinburgh high risk study (2007) (0)
Explorer Hippocampal function in schizophrenia and bipolar disorder (2017) (0)
Gene-environment interactions in the Edinburgh high risk study (2004) (0)
The nature and the management of schizophrenia. (1991) (0)
A Comparison of SPM’96 with ROI Analysis in Serotonin Transporter Imaging (1998) (0)
Affective and Schizophrenic Disorders: New Approaches to Diagnosis and Treatment (1984) (0)
A magnetic resonance studyofearly schizophrenia (1986) (0)
MHPG excretion in endogenous depression: Relationship to clinical state and the effects of ECT (2004) (0)
Structural and functional imaging predictors and associations of psychosis development in the Edinburgh high risk study (2004) (0)
Biological Psychiatry. 1981. Edited by C. Perris, G. Struwe and B. Jansson Amsterdam: Elsevier. 1982. Pp 1327. $198.00, Dfl. 425. (1982) (0)
Correction (1985) (0)
Affective Disorders: Psychopathology and Treatment. By Eduardo R. Val, F. Moises, Gaviria and Joseph A. Flaberty. London: Year Book Publishers. 1982. Pp 487. £38.50. (1983) (0)
Scotlandof psychiatric morbidity among remand prisoners in (2011) (0)
The development of psychosis in the Edinburgh High Risk Study (2002) (0)
New Look at Monoamine Oxidase Inhibitors (1973) (0)
Errorless learning as a treatment for memory impaired schizophrenic patients (1998) (0)
Patterns of grey matter density partially separate schizophrenia and bipolar disorder (2004) (0)
The new consultant contract (1979) (0)
[No Title] (1982) (0)
S.06.01 Does early treatment have an effect on outcome? (1997) (0)
Structural Magnetic Resonance Imaging (MRI) in obligate carriers of genes for schizophrenia, their affected and unaffected siblings (2000) (0)
100 cases in the Edinburgh High-Risk Study. People at risk of schizophrenia. Sample characteristics of the first (2011) (0)
Structural and functional neuroimaging studies of schizophrenia and bipolar disorder (2008) (0)
Presenile Dementia in Scotland: a Clinical and Genetic Analysis (1996) (0)
Authors' reply (1995) (0)
Neuropsychiatry. By Michael R. Trimble. Chichester: John Wiley. 1981. Pp 287. £13.60. (1981) (0)
The Health Advisory Service—A quango running wild? (1986) (0)
Modern Perspectives in Psychiatry, No. 10. Modern Perspectives in Clinical Psychiatry. Edited by John G. Howells New York: Brunner/Mazel. 1988. 392 pp. $40.00. (1989) (0)
Cortical thickness in a cohort of individuals at high genetic risk of schizophrenia. (2009) (0)
Structural MRI findings and associations in young people at cognitive high risk of schizophrenia (2008) (0)
Temporal lobe asymmetries as a clue to the aetiology of schizophrenia (1991) (0)
THE TIME SEQUENCE OF STRUCTURAL BRAIN ABNORMALITIES IN SCHIZOPHRENIA (2010) (0)
Antecedents of schizophrenia and affective disorders — social behaviour at 7 and 11 years of age recorded in the national child development study (1993) (0)
Monoamines, monoamine oxidase inhibitors and depression (1976) (0)
Clobazam: Human Psycho pharmacology and Clinical Applications. Edited by I. Hindmarsh, P. D. Stonier and M. R. Trimble. Oxford: Oxford University Press for the Royal Society of Medicine. 1985. Pp. 215. £8.00. (1986) (0)
Qualitative brain assessment in schizophrenia, high risk subjects and normal controls on MRI (1996) (0)
Iconography : Progressive grey matter loss in patients with bipolar disorder (2007) (0)
overlap between them. Phenomenology of organic and functional psychoses and the (2012) (0)
Research in the Schizophrenic Disorders: The Stanley R. Dean Award Lectures. Vol. II. By Robert Cancro and Stanley R. Dean. Lancaster: MTP Press. 1985. Pp 332. £47.50. (1986) (0)
Functional MRI changes relate to BDNF val66met polymorphism in the Edinburgh high risk study (2007) (0)
Poster #145 IMPAIRMENT IN COGNITIVE FLEXIBILITY IN PATIENTS WITH BIPOLAR DISORDER VERSUS PATIENTS WITH SCHIZOPHRENIA (2012) (0)

This paper list is powered by the following services:

Other Resources About Eve Johnstone

en.wikipedia.org

What Schools Are Affiliated With Eve Johnstone?

Eve Johnstone is affiliated with the following schools:

Eve Johnstone's Academic­Influence.com Rankings